NDI Neuro Device Innovations is a Cleveland-based hybrid investment and commercialization platform focused exclusively on neurodevices. It combines capital with hands-on development, engineering, regulatory, and commercialization support, making it much more operational than a traditional venture fund. Its long-standing specialization gives it a very distinct place in the neurotech ecosystem.

The firm’s portfolio spans pain, depression, epilepsy, Parkinson’s disease, stroke, obesity, and neuromodulation, with investments in companies such as Checkpoint Surgical, Deep Brain Innovations, and SPR Therapeutics. NDI’s model is particularly attractive for founders building devices that need help moving from concept into regulated product development. It is not just writing checks; it is helping build and advance neurodevice programs end to end.

NDI operates from the US but targets the neurodevice market broadly. For neurotech founders, it is one of the clearest specialist groups for device-heavy companies needing engineering and regulatory support alongside funding. It is especially relevant for implantables, neuromodulation, and clinically focused neurotechnology platforms.

‍